A COMPARATIVE STUDY OF EFFICACY OF NEBULIZER AND METERED DOSE INHALER WITH SPACER IN THE TREATMENT OF ACUTE ASTHMA IN CHILDREN

Similar documents
J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 65/Nov 27, 2014 Page 13575

5. Treatment of Asthma in Children

The use of text messaging to improve asthma control: a pilot study using the mobile phone short messaging service (SMS)

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

Sponsor Novartis Pharmaceuticals

Classifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age

Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

SYNOPSIS. Risperidone: Clinical Study Report CR003274

The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.

Outcome of Drug Counseling of Outpatients in Chronic Obstructive Pulmonary Disease Clinic at Thawangpha Hospital

A Disease Management Program in France : Lessons from the RESALIS Experiment 18 Months Before and 12 Months After Public Health Interventions

Asthma in Infancy, Childhood and Adolescence. Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California

Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma

The Annual Direct Care of Asthma

EHR Demo Scenarios - Pediatrics. Female child 18 months old, here with mother for well child exam, including immunizations.

UNDERSTANDING AND LEARNING ABOUT STUDENT HEALTH

VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS

Standardizing the measurement of drug exposure

Ferry Beach Ecology School Medical Management Plan -- Student with Chronic Illness or Severe Allergy

Ohio Department of Health Authorization for Student Possession and Use of an Asthma Inhaler In accordance with ORC /3313.

J. A. HILDES NORTHERN MEDICAL UNIT DEPARTMENT OF COMMUNITY HEALTH SCIENCES AND DEPARTMENT OF PEDIATRICS AND CHILD HEALTH FACULTY OF MEDICINE

Tests. Pulmonary Functions

The Right Medicines Can Help You Get Control of Asthma. BlueCare SM TennCareSelect

Asthma. Micah Long, MD

Air or oxygen as driving gas for nebulised salbutamol

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

New 7/1/2015 MCFRS 1

Allergy Emergency Treatment Protocol

9/16/2014. Anti-Immunoglobulin E (IgE) Omalizumab (Xolair ) Dosing Guidance

THE EUROPEAN COMMUNITY RESPIRATORY HEALTH SURVEY II ECRHS II LUNG FUNCTION PROTOCOL, DATA SHEETS AND LUNG FUNCTION QUESTIONNAIRE

Efficacy, safety and preference study of a insulin pen PDS290 vs. a Novo Nordisk marketed insulin pen in diabetics

Recommended guidelines for. schools

Epinephrine Auto Injector Interim Policy (Amended March 12, 2008)

2.0 Synopsis. Vicodin CR (ABT-712) M Clinical Study Report R&D/07/095. (For National Authority Use Only) to Part of Dossier: Volume:

GENERAL INFORMATION. Adverse Event (AE) Definition (ICH GUIDELINES E6 FOR GCP 1.2):

ADULT BASIC LIFE SUPPORT (BLS) AWARENESS AND KNOWLEDGE AMONG MEDICAL AND DENTAL INTERNS COMPLETING INTERNSHIP FROM DEEMED UNIVERSITY

ADMINISTRATION OF MEDICATION TO STUDENTS POLICY

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

MEDICATION ADMINISTRATION TO STUDENTS PROCEDURES

Virginia Tech Departmental Policy 27 Sports Medicine Key Function:

FREEDOM C: A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C

Doncaster & Bassetlaw Medicines Formulary

ADMINISTRATION OF DRUG PRODUCTS/MEDICATIONS TO STUDENTS

It is recommended that the reader review each medical directive presented in this presentation along with the actual PCP Core medical directive.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Trial Description. Organizational Data. Secondary IDs

If#Your#Child#Requires#Medication#While#at#Camp:#

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

Guidance for Industry. Integration of Dose-Counting Mechanisms into MDI Drug Products

New River Health will bill private insurance, Medicaid, and CHIP for eligible students. No child will be denied services due to inability to pay.

Emergency Treatment of Anaphylaxis Policy and Guidelines

Study Designs. Simon Day, PhD Johns Hopkins University

Version History. Previous Versions. Policy Title. Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author

Author(s) White, Daniel C.; Kelly, Brendan D.; Casey, Patricia R. Irish Journal of Medical Science, 178 (4):

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:

POLICY of 5. Students ADMINISTRATION OF MEDICATION

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Active centers: 2. Number of patients/subjects: Planned: 20 Randomized: Treated: 20 Evaluated: Efficacy: 13 Safety: 20

How To Improve Care For Bronchiolitis

4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED

Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology

Protecting your child against flu

PERRYSBURG EXEMPTED VILLAGE SCHOOL DISTRICT

Administration of Medicines and Healthcare Needs in Schools

NCT sanofi-aventis HOE901_3507. insulin glargine

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP

T HE ROLE OF THE PHARMACIST IN IMPROVING ASTHMA CARE NIH PUBLICATION NO JULY 1995 NATIONAL INSTITUTES. National Heart, Lung,

Asthma: Practical Tips For Coaches. Developed by: The Minnesota Department of Health Asthma Program - updated 2008

Allergy Action Plan For the School Year

Childhood Asthma / Wheeze

Chapter Seven. Multiple regression An introduction to multiple regression Performing a multiple regression on SPSS

An Overview of Asthma - Diagnosis and Treatment

Required by statute (Chapter 423 of the Laws of 2014).

81 First Responder Respiratory

Breathe With Ease. Asthma Disease Management Program

SMO: Anaphylaxis and Allergic Reactions

Sample Paper for Research Methods. Daren H. Kaiser. Indiana University Purdue University Fort Wayne

Proving Respiratory Therapy value in the Affordable Care Pay Structure

to Part of Dossier: Name of Active Ingredient: Title of Study: Quality of life study with adalimumab in rheumatoid arthritis. ESCALAR.

1. NAME 2. SOCIAL SECURITY NUMBER # 4. PRESENT OCCUPATION 5. PLANT 6. ADDRESS 8. TELEPHONE NUMBER 9. INTERVIEWER

Immunology, J Allergy Clinical Immunology 1998; Vol.102, No. 2,

Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital

Asthma: Practical Tips For P.E. & H.E. Teachers

Asthma Management Policy

SYNOPSIS. 2-Year (0.5 DB OL) Addendum to Clinical Study Report

OSHA INITIAL ASBESTOS MEDICAL QUESTIONNAIRE

COPD PROTOCOL CELLO. Leiden

University of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol

Guidance for Industry Migraine: Developing Drugs for Acute Treatment

Asthma and Housing What s the Evidence What Can We Do?

Yoon Nofsinger, M.D. Tampa ENT Associates, 3450 East Fletcher Avenue, Tampa, FL Phone (813) , Fax (813)

COPD and Asthma Differential Diagnosis

ASTHMA IN INFANTS AND YOUNG CHILDREN

Measurement and Measurement Scales

COPD Prescribing Guidelines

Emotional dysfunction in psychosis.

DRAFT FORMULA TO DETERMINE THE QUANTUM OF COMPENSATION IN CASE OF CLINICAL TRIAL RELATED INJURY (OTHER THAN DEATH)

Clinical Study Synopsis

Transcription:

A COMPARATIVE STUDY OF EFFICACY OF NEBULIZER AND METERED DOSE INHALER WITH SPACER IN THE TREATMENT OF ACUTE ASTHMA IN CHILDREN Jeyaraman Balasubramanian 1, Chelladurai Vasanthamalar, Soundaian Balasankar 3, Ganeshapillai Mathevan 4 1Assistant Professor, Department of Paediatrics, Institute of Child Health & Research Centre, Government Rajaji Hospital, Madurai Medical College, Madurai, Tamilnadu. Post Graduate, Department of Paediatrics, Institute of Child Health & Research Centre, Government Rajaji Hospital, Madurai Medical College, Madurai, Tamilnadu. 3Professor, Department of Paediatrics, Institute of Child Health & Research Centre, Government Rajaji Hospital, Madurai Medical College, Madurai, Tamilnadu. 4Director, Department of Paediatrics, Institute of Child Health & Research Centre, Government Rajaji Hospital, Madurai Medical College, Madurai, Tamilnadu. ABSTRACT BACKGROUND To compare the relative efficacy of Nebulizer and Metered Dose Inhaler (MDI) with spacer for the administration of aerosolized salbutamol in the of acute asthma. MATERIALS AND METHODS A randomized, prospective, interventional study was conducted on 400 children aged - years with acute asthmatic attack. The subjects were randomly assigned to two groups for salbutamol administration, Group I was given salbutamol by jet nebulizer and Group II by metered dose inhaler with spacer. Baseline characteristics were recorded (Duration of illness, nature of medications, family history, allergy history, etc.). Children were categorized into low, middle and high grade according to clinical asthma score (Based on presence of wheezing, retractions, dyspnoea). Initial assessment was done at zero minutes. Clinical responses were assessed at 0, 40 and 60 minutes intervals after. Poor response at 60 minutes were considered as failure. RESULTS In low grade, there was no significant difference between both groups. In middle grade, Group II required less number of (p value<0.001), which was statistically significant. In high grade also, the p value is 0.03 and was significant. The overall clinical response among Group I and Group II was statistically significant. There was no statistical significance among the failure in both groups. CONCLUSION MDI with spacer is an effective alternative to nebulizer for the administration of aerosolized drugs in acute asthmatic attack in paediatric emergency department. Use of MDI with spacer is more effective than nebulizer for the of moderate-to-severe asthma. Nebulization has some limitations like inconvenience, slow implementation, high cost, power requirement and uncontrolled particle sizes, but none in case of MDI. KEYWORDS Nebulizer, Metered Dose Inhaler, Acute Asthma. HOW TO CITE THIS ARTICLE: Balasubramanian J, Vasanthamalar C, Balasankar S, et al. A comparative study of efficacy of nebulizer and metered dose inhaler with spacer in the of acute asthma in children. J. Evolution Med. Dent. Sci. 016;(39): 467-471, DOI: 10.1460/jemds/016/0 INTRODUCTION Many consensus protocols and guidelines have been published for improving the of asthma. The first line of is inhaled beta- agonist (Salbutamol). In general, beta- agonist administered via Nebulizer is the standard for asthma exacerbations. 1 But there are some limitations in nebulization like power requirement, equipment failure, maintenance charges, some children may not tolerate noisy equipment. Metered Dose Inhaler (MDI), which is small and portable have advantages over nebulizer. Guidelines from GINA recommend MDI for children with asthma due to increased efficacy and decreased cost. () This study was conducted to compare the relative efficacy of MDI with spacer and nebulizer for the administration of aerosolized salbutamol in the of acute asthma in children. Financial or Other, Competing Interest: None. Submission 19-03-016, Peer Review 4-04-016, Acceptance 30-04-016, Published 13-0-016. Corresponding Author: Dr. Jeyaraman Balasubramanian, Assistant Professor, Department of Paediatrics, Institute of Child Health & Research Centre, Government Rajaji Hospital, Madurai-600, Tamilnadu. E-mail: drbaladch@yahoo.co.in DOI: 10.1460/jemds/016/0 AIM OF THE STUDY To compare the relative efficacy of Metered Dose Inhaler (MDI) with spacer and Nebulizer for the administration of aerosolized salbutamol in the of acute asthma. MATERIALS AND METHODS Setting This study was done at Institute of Child Health and Research Centre, Government Rajaji Hospital, Madurai. J. Evolution Med. Dent. Sci./eISSN- 78-480, pissn- 78-4748/ Vol. 0/ Issue 39/ May 16, 016 Page 467

Study Period year from September 0 to August 013. Study Design Randomized, interventional study. Inclusion Criteria Children aged years with acute asthmatic attack, irrespective of the previous. Exclusion Criteria Children diagnosed as having concurrent pneumonia, chronic lung disease, cyanotic congenital heart disease, suspected foreign body aspiration, very sick requiring intensive care. Ethical Clearance Obtained from Ethical Committee, Madurai Medical College and Government Rajaji Hospital, Madurai. METHODOLOGY Informed consent was obtained from the parent/guardian for the intervention. A Special Proforma was Designed to Record the following Information Demographic data. Onset of first episode and frequency of symptoms. Family history. Allergic history. Clinical asthma score. The cases were enrolled in group I or group II by randomization. Block randomization was done using the software SAS 9.1. Children were administered aerosolized Salbutamol. Group I was given by Jet Nebulizer and Group II by MDI with spacer. For Nebulization, 0.1 mg/kg (Max. mg) of salbutamol diluted in. ml Normal Saline was administered through nebulizer. For metered dose inhaler, 4 puffs for <6 years and 8 puffs for >6 years (1 puff delivering 100 ug) was administered with spacer with or without mask. Spacer with a volume of 70 ml with one-way valve was used. Face mask attachment was required in younger (Less than 3 years) children. Initial assessment was done at zero minutes by clinical asthma score. Score Wheeze Retraction Dyspnoea 0 No Wheeze No Retraction No Dyspnoea 1 End Expiratory Intercostal Retraction Normal Activity Inspiratory & Expiratory Intercostal/Suprasternal Retraction 3 Audible/Silent Nasal Flare 8 Words Not Speaking Sentence score 9 (Wheeze 3, Retraction-3, Dyspnoea-3). The cases are graded as below according to their score: Low : 0 Middle : 3 6 High : 7 9 Clinical responses were assessed at 0, 40 and 60 minutes intervals by an assessor who was not aware to which group the patient belongs. Poor response at 60 minutes were considered as failure. Statistical Analysis All data were entered in Excel 7 and statistical analysis was performed using the statistical software SPSS 16.0. For all categorical variables, Pearson Chi square test and Fisher s exact test were used and for non-parametric data, Mann Whitney U test was used. p value less than 0.0 is considered to be statistically significant. Randomization Out of total 400 cases, were in Group I and were in Group II as divided by a computer generated sequence. Age Distribution Out of 400 cases, 6% (n=60) were below 6 years and 3% (n=140) were above 6 years. Sex Distribution Out of 400 cases, 9% (n=3) were males and 41% (n=16) were females. Male:Female ratio is 1.4:1. Family History Out of 400 cases, 46.3% (n=18) had positive family history; 89 cases (48%) in nebulizer group, 96 cases (%) in MDI group. Allergic History Out of total 400 cases,.8% (n=91) had allergic history. 40 cases (44%) in nebulizer group, 1 cases (6%) in MDI group. Previous Treatment History Out of 400 cases, 376 cases (94%) had previous history of in the form of oral medications, injection and inhalation, 0 cases (4%) in nebulizer group and 4 cases (46%) in MDI group, but nobody was on regular medications. (We used to get such type of patients only in our hospital) Remaining 4 cases (6%) came with first attack of wheezing. In our study, there is no statistical significance among age and (p=0.098), sex and (p=0.761), positive family history and (p=0.483), presence of allergic history and (p=0.074). Group-I Group-II Low 49 (4.%) 43 (1.%) Middle 104 (%) 106 (3%) High 47 (3.%) 1 (.%) (100%) (100%) Table 1: Grading of Severity Group I and II were graded on the basis of clinical Asthma score into low, middle and high grade. J. Evolution Med. Dent. Sci./eISSN- 78-480, pissn- 78-4748/ Vol. 0/ Issue 39/ May 16, 016 Page 468

Number of Vs (Low Grade) of mode of 49 49 43 43 Table : Clinical Responses: Low Grade 9 4 Hence, in low grade, no difference in clinical response between both the groups. Number of Vs (Middle Grade) -(p=0.001). Number of % % % % 79 76.0% 3.1% 1.9% 104 100 94.3% 6.7% 106 Table 3: Clinical Responses: Middle Grade 9 8.% 9 13.8% 1.0% 10 There is significant statistical difference between groups (p=0.001). In middle grade, clinical response to MDI with spacer is better than nebulizer. Number of Vs (High Grade) - (p=0.03). of Treatment Failure 10 1.3% 36.% 8.0%.% 47 43.1% 0 39.% 4 7.8% 9.8% 1 Table 4: Clinical Responses: High Grade 3 3.7% 37 37.8%.%.3% 98 In high grade, clinical response to MDI with spacer is better than nebulizer. Failure rate is more in nebulizer group than in MDI with spacer group. There is statistical significance among high grade (p=0.03). Number of Vs (p=0.013) of Treatmen t Failure cases% cases% treatmen t Nebulizatio MDI n 138 69.0% 40 0.0% 10.0% 6.0% Table : Overall Responses 16 8.% 6 13.0% 4.0%.% 303 7.8% 66 16.% 14 3.% 4.3% 400 The overall clinical responses among Group I and Group II is statistically significant (p=0.013). MDI with spacer is better than nebulizer in all grades of severity. Treatment Failure Improved Cases Treatment Failure Group I 188 94.0% 6.0% 100% Group II 19 97.%.% 100% Here, the p value is 0.083 and is not statistically significant. DISCUSSION 1. Age Distribution In our study, out of 400 cases 6% (n=60) were less than 6 years and 3% (n=140) were above 6 years. Mean age in our study was 3 years. This was similar to Carlos Rodrigo et al study, in which the average age was 33.1 months.. Sex Distribution Out of 400 cases, 8% (n=3) were males and 41% (n=16) were females. This was similar to Chalerat Direcwatanachai et al study, in which 6% were males and 3% were females. Male children outnumber female. 3. Family History Of 400 cases, 46.3% (n=18) had positive family history. This was similar to Bijanzadeh Matdi et al study conducted at Department of Paediatrics, Mysore Medical College and J. Evolution Med. Dent. Sci./eISSN- 78-480, pissn- 78-4748/ Vol. 0/ Issue 39/ May 16, 016 Page 469

Research Institute, Mysore, in which 44.% of cases had positive family history. 4. Allergic History Out of total 400 cases,.8% (n=91) had allergic history. Studies show that those children with asthma more often have allergic history.. Grading of Severity In our study on the basis of clinical Asthma score in Group I, 4.%, %, 3.% constituted low, middle and high grade respectively. In Group II 1.%, 3% and.% constituted low, middle and high grade respectively. This was similar to Syed Waseem Jamalvi et al study conducted at Agakhan University Hospital, Karachi. (3) In that study, 3.8% and 4.% represented mild-to-moderate asthma in Group A and Group B using Medical Scoring system. This was also similar to Vandana Batra et al study done at Maulana Azad Medical College, New Delhi. (4) 6. Clinical Responses Initial assessment was done for all children at 0 minutes. Clinical responses were assessed for both groups at 0, 40 and 60 minutes. Number of required was taken into account. In Low grade, there are 49 cases in Group I and 43 cases in Group II. All cases in both groups required one. There was no statistical difference between both groups. In Middle grade of the total 104 cases in Group I 76% (n=79) required once,.1% cases (n=3) required twice and 1.9% (n=) required thrice. In Group II, of the 106 cases 94.3% (n=100) cases required one and.7% (n=6) required two s and none of them required third. Here, the p value=0.001 which was statistically significant. In High grade, of the total 47 cases in Group I 1.3% (n=10) cases required once, 36.% (n=) required twice, % (n=8) required thrice and.% (n=) were considered failure. In Group II, of 1 cases 43.1 (n=) cases required once, 39.% (n=0) required twice, 7.8% (n=4) required thrice and 9.8% (n=) were considered failure. Fig. 1: The Flowchart for Randomization, Intervention and Assessment CAS-Clinical Asthma Score, MDI Metered Dose Inhaler, TF Treatment Failure J. Evolution Med. Dent. Sci./eISSN- 78-480, pissn- 78-4748/ Vol. 0/ Issue 39/ May 16, 016 Page 470

7. Overall Responses The overall clinical responses of all the cases in each group was as follows: In Group I, out of cases 69% (n=138) required one dose, 0% (n=40) required two doses and 10% (n=) required three doses. In Group II, out of cases 8.% (n=16) required one dose, 13% (n=6) required two doses and % (n=) required three doses. This was compared against the variables given by Chalerat et al study. () Comparison between our study and Chalerat et al study. () Gr. I (n=) Our Study Gr. II (n=) Chalerat et al Nebulizer (n=77) MDI with Volumatic (n=68) dose 69 8. 9.7 47.1 doses 0 13 1.6 0.6 doses 3.9 4.4 8. Treatment Failure At the end of 60 minutes, if there was no clinical improvement they were considered as failure. In our study, in Group I and Group II, 6% (n=) and.% (n=) respectively were considered failure. The following is the number of failure cases in various studies. Nebulizer (%) MDI (%) Our Study 6. Chalerat et al ().6 1. Syed Waseem et al (3) 10.6 4.8 CONCLUSION 1. MDI with spacer is an effective alternative to Nebulizer for the administration of salbutamol in acute asthmatic attack in paediatric emergency department.. Due to the economic and power requirement constraints, MDI with spacer is strongly recommended than nebulizer. 3. Use of MDI with spacer is even more effective than nebulizer in moderate-to-severe asthma. RECOMMENDATIONS MDI with spacer can replace nebulizer for the of acute asthma, both in hospital and in household. REFERENCES 1. Robert M Kliegman, Bonita MD Stanton, Joseph St Geme, et al. Nelson text book of paediatrics. Elsevier Saunders 011;19 th edn.. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) 6. Available at http://ginasthma.org. 3. Syed Waseem Jamalvi, Syed Jamal Raza, Farah Naz, et al. Management of acute asthma in children using metered dose inhaler and small volume nebulizer. JPMA 6;6():9-9. 4. Vandana Batra, Sethi GR, Sachdev HP. Comparative efficacy of jet nebulizer and metered dose inhaler with spacer device in the of acute asthma. Indian paediatrics 1997;34(6):497-03.. Chalerat Direkwatanachai, Teeratakulpisarn J, Suntornlohanakul S, et al. Comparison of salbutamol efficacy in children- via the metered-dose inhaler (MDI) with volumatic spacer and via the dry powder inhaler, easyhaler, with the nebulizer-in mild to moderate asthma exacerbation: a multicenter, randomized study. Asian Pac J Allergy Immunol 011;9(1):-33. J. Evolution Med. Dent. Sci./eISSN- 78-480, pissn- 78-4748/ Vol. 0/ Issue 39/ May 16, 016 Page 471